Palliative pylorus-preserving pancreatic head resection and postoperative chemotherapy versus primary chemotherapy alone for patients with advanced carcinoma of the pancreatic head

Completed

• Conditions: Pancreatic head carcinoma; Cancer

• Registration Number: ISRCTN20060588
• Lead Sponsor: Humboldt University Berlin (Germany)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-07-02
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Medical centres experienced in surgical and medical care of patients with pancreatic head carcinoma.

Exclusion Criteria

No exclusion criteria.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival, measured after 3, 6 and 12 months

Secondary Outcome Measures

Name	Time	Method
1. Quality of life, measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer patients (EORTC QLQ-C30) and the EORTC Quality of Life Questionnaire for Pancreatic cancer (QLQ PAN26). This will be measured after 3, 6 and 12 months<br>2. Surgical complications, measured after 3, 6 and 12 months<br>3. Toxicity of chemotherapy, measured after 3, 6 and 12 months